BYRN vs MRK · P/E 18, rev $16.4M vs P/E 33, rev $16.61B
Byrna Technologies Inc (BYRN) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Byrna Technologies Inc (BYRN) is a aerospace & defense company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE.
Latest reported BYRN revenue for 2026-05-31 was $16.4M. Net income was -$10.1M. Revenue was down 43.6% from 2026-02-28 to 2026-05-31. BYRN currently screens at market cap $148.6M and trailing P/E 18.2.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
BYRN currently screens at market cap $148.6M and trailing P/E 18.2. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the BYRN and MRK stock pages for the full models.
Not investment advice.